_id
690daab7ccc777a4e85d08de
Ticker
AFJKU
Name
Aimei Health Technology Co., Ltd Unit
Exchange
NASDAQ
Address
10 East 53rd Street, New York, NY, United States, 10022
Country
USA
Sector
Financial Services
Industry
Shell Companies
Currency
USD
Website
-
Description
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Last Close
64.33
Volume
-
Current Price
64.33
Change
-0.67
Last Updated
2026-01-20T14:51:08.106Z
Image
-
Ipo Date
2023-12-04T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
130151
Operating Income
-130152
Interest Expense
-
Pretax Income
352019
Net Income
352019
Eps
0.08809872931950158
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
352019
Operating Margin
-
Total Other Income Expense Net
482171
Cash
2979
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
24948
Property Plant Equipment
-
Total Assets
45468518
Payables
-
Short Term Debt
1655400
Long Term Debt
-
Total Liabilities
3464428
Equity
42004090
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
34043
Cash From Operations
-96109
Capital Expenditures
0
Cash From Investing
-450000
Cash From Financing
546950
Net Change In Cash
841
Cf_currency_symbol
USD
PE
-
PB
6.119535118841998
ROE
0.8380588652200297
ROA
0.7742038128447468
FCF
-96109
Fcf Percent
-
Piotroski FScore
2
Health Score
51
Deep Value Investing Score
5.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
7.3
Garp Investing Score
4.5
Growth Investing Score
2.5
Momentum Investing Score
5.5
Net Net Investing Score
2
Quality Investing Score
5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
130151
Quarters > 0 > income Statement > operating Income
-130152
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
352019
Quarters > 0 > income Statement > net Income
352019
Quarters > 0 > income Statement > eps
0.08809872931950158
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3995733
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
352019
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
482171
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2979
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24948
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
45468518
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
1655400
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3464428
Quarters > 0 > balance Sheet > equity
42004090
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
352019
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
34043
Quarters > 0 > cash Flow > cash From Operations
-96109
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-450000
Quarters > 0 > cash Flow > cash From Financing
546950
Quarters > 0 > cash Flow > net Change In Cash
841
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.08809872931950158
Quarters > 0 > ratios > PB
6.119535118841998
Quarters > 0 > ratios > ROE
0.8380588652200297
Quarters > 0 > ratios > ROA
0.7742038128447468
Quarters > 0 > ratios > FCF
-96109
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
41604
Quarters > 1 > income Statement > operating Income
-41604
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
424970
Quarters > 1 > income Statement > net Income
424970
Quarters > 1 > income Statement > eps
0.06941988485940175
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6121733
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-41604
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
466574
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2138
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
44638
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
44556037
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
1205400
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2903966
Quarters > 1 > balance Sheet > equity
41652071
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
424970
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-160146
Quarters > 1 > cash Flow > cash From Operations
-201750
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-450000
Quarters > 1 > cash Flow > cash From Financing
646543
Quarters > 1 > cash Flow > net Change In Cash
-5207
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.06941988485940175
Quarters > 1 > ratios > PB
9.454777984268777
Quarters > 1 > ratios > ROE
1.0202854018951424
Quarters > 1 > ratios > ROA
0.9537876988476331
Quarters > 1 > ratios > FCF
-201750
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
51
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
413414
Quarters > 2 > income Statement > operating Income
-413414
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
184662
Quarters > 2 > income Statement > net Income
184662
Quarters > 2 > income Statement > eps
0.02045889652116109
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9026000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
184662
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
598076
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
7345
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
8022
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
43602847
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
755400
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2375746
Quarters > 2 > balance Sheet > equity
41227101
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
184662
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
189405
Quarters > 2 > cash Flow > cash From Operations
-224009
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
30787800
Quarters > 2 > cash Flow > cash From Financing
-30584654
Quarters > 2 > cash Flow > net Change In Cash
-20863
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.02045889652116109
Quarters > 2 > ratios > PB
14.08400217129019
Quarters > 2 > ratios > ROE
0.44791410388035774
Quarters > 2 > ratios > ROA
0.42350904288428687
Quarters > 2 > ratios > FCF
-224009
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
50
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1325530
Quarters > 3 > income Statement > cost Of Revenue
662765
Quarters > 3 > income Statement > gross Profit
662765
Quarters > 3 > income Statement > operating Expenses
402021
Quarters > 3 > income Statement > operating Income
-402021
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
444113
Quarters > 3 > income Statement > net Income
444113
Quarters > 3 > income Statement > eps
0.04920374473742522
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
9026000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
444113
Quarters > 3 > income Statement > operating Margin
-30.329075916803088
Quarters > 3 > income Statement > total Other Income Expense Net
846134
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
28208
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
30384
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
73814933
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
227700
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1506994
Quarters > 3 > balance Sheet > equity
72307939
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
444113
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
206890
Quarters > 3 > cash Flow > cash From Operations
-195131
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-277700
Quarters > 3 > cash Flow > cash From Financing
397480
Quarters > 3 > cash Flow > net Change In Cash
-75351
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.04920374473742522
Quarters > 3 > ratios > PB
8.030135943993647
Quarters > 3 > ratios > ROE
0.6141967343309287
Quarters > 3 > ratios > ROA
0.6016573909238664
Quarters > 3 > ratios > FCF
-195131
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.14720979532715217
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1065000
Annuals > 0 > income Statement > operating Income
-1065000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
2552000
Annuals > 0 > income Statement > net Income
2552000
Annuals > 0 > income Statement > eps
0.28273875470861953
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
9026000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1065000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3617000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
28208
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
30384
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
73814933
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
227700
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1506994
Annuals > 0 > balance Sheet > equity
72307939
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2552215
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
392497
Annuals > 0 > cash Flow > cash From Operations
-672289
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-277700
Annuals > 0 > cash Flow > cash From Financing
397480
Annuals > 0 > cash Flow > net Change In Cash
-552509
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.28273875470861953
Annuals > 0 > ratios > PB
8.030135943993647
Annuals > 0 > ratios > ROE
3.5293496610379114
Annuals > 0 > ratios > ROA
3.4572950164433527
Annuals > 0 > ratios > FCF
-672289
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
47
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
28459
Annuals > 1 > income Statement > operating Income
-28459
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
171389
Annuals > 1 > income Statement > net Income
171389
Annuals > 1 > income Statement > eps
0.018988366939951252
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
9026000
Annuals > 1 > income Statement > income Tax Expense
171389
Annuals > 1 > income Statement > EBITDA
171389
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
199848
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
580717
Annuals > 1 > balance Sheet > short Term Investments
69889848
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
580717
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
70470565
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
714841
Annuals > 1 > balance Sheet > equity
69755724
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
171389
Annuals > 1 > cash Flow > depreciation
199849
Annuals > 1 > cash Flow > change In Working Capital
24841
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-69690000
Annuals > 1 > cash Flow > cash From Financing
70270717
Annuals > 1 > cash Flow > net Change In Cash
580717
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
0.018988366939951252
Annuals > 1 > ratios > PB
8.323941702619273
Annuals > 1 > ratios > ROE
0.24569883325990566
Annuals > 1 > ratios > ROA
0.24320650756808887
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
50
Valuation > metrics > PE
0.08809872931950158
Valuation > metrics > PB
6.119535118841998
Valuation > final Score
40
Valuation > verdict
2.4% Overvalued
Profitability > metrics > ROE
0.8380588652200297
Profitability > metrics > ROA
1411.0109026775694
Profitability > final Score
47
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.08247834913219165
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
0.015070677781805002
Liquidity > metrics > Quick Ratio
0.015070677781805002
Liquidity > final Score
11
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
47
Prev Profitabilities > 1
46
Prev Profitabilities > 2
61
Prev Risks > 0
60
Prev Risks > 1
80
Prev Risks > 2
80
Prev Liquidities > 0
12
Prev Liquidities > 1
11
Prev Liquidities > 2
17
Updated At
2026-01-20T21:20:38.532Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.06
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.07
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.07
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.03
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.05
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.05
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0824
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0675
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.0837
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.0194
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Setups: What is the dividend yield of Azenta Inc - Trade Signal Summary & Daily Stock Trend Watchlist baoquankhu1.vn
Read more →Will AFJKU stock split attract more investors - Weekly Gains Summary & Fast Moving Market Watchlists bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Aimei Health Technology Co., Ltd Unit
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.06
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.